{"name":"Pappas Ventures","permalink":"pappas-ventures","crunchbase_url":"http://www.crunchbase.com/financial-organization/pappas-ventures","homepage_url":"http://www.pappasventures.com","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"919-998-3300","description":"","email_address":"","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Fri May 22 22:11:47 UTC 2009","updated_at":"Wed Jun 17 22:34:58 UTC 2009","overview":"<p>At Pappas Ventures, their sole focus is investing in the life sciences â€“ biotechnology, specialty pharmaceuticals, drug delivery, medical devices and related ventures. Their success, however, is not simply a product of investment capital. They bring experience, creativity and passion to each and every partnership. And in so doing, they are bringing promising technologies to commercial application â€“ from concept to commerce.</p>","image":{"available_sizes":[[[150,131],"assets/images/resized/0004/9245/49245v1-max-150x150.png"],[[164,144],"assets/images/resized/0004/9245/49245v1-max-250x250.png"],[[164,144],"assets/images/resized/0004/9245/49245v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"","address1":"2520 Meridian Parkway  Suite 400","address2":"","zip_code":"27713","city":"Durham","state_code":"NC","country_code":"USA","latitude":35.91063,"longitude":-78.8968482},{"description":"Mailing address","address1":"P. O. Box 110287","address2":"","zip_code":"27709","city":"Research Triangle Park","state_code":"NC","country_code":"USA","latitude":35.912388,"longitude":-78.8665733}],"relationships":[{"is_past":false,"title":"Managing Partner","person":{"first_name":"Art","last_name":"Pappas","permalink":"art-pappas","image":{"available_sizes":[[[132,132],"assets/images/resized/0004/9247/49247v1-max-150x150.jpg"],[[132,132],"assets/images/resized/0004/9247/49247v1-max-250x250.jpg"],[[132,132],"assets/images/resized/0004/9247/49247v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Partner","person":{"first_name":"Eric","last_name":"W. Linsley","permalink":"eric-w-linsley","image":{"available_sizes":[[[132,132],"assets/images/resized/0004/9248/49248v1-max-150x150.jpg"],[[132,132],"assets/images/resized/0004/9248/49248v1-max-250x250.jpg"],[[132,132],"assets/images/resized/0004/9248/49248v1-max-450x450.jpg"]],"attribution":""}}}],"investments":[{"funding_round":{"round_code":"b","source_url":"http://venturebeat.com/2008/03/10/life-science-briefing-monday-march-10-2008/","source_description":"BrainCells raises $30M","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":3,"funded_day":null,"company":{"name":"BrainCells","permalink":"braincells","image":{"available_sizes":[[[150,61],"assets/images/resized/0004/3268/43268v1-max-150x150.png"],[[191,78],"assets/images/resized/0004/3268/43268v1-max-250x250.png"],[[191,78],"assets/images/resized/0004/3268/43268v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.leadtherapeutics.com/pr/2007/pr_110507.html","source_description":"LEAD Therapeutics Raises $17 Million in Series A Financing","raised_amount":17000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":11,"funded_day":5,"company":{"name":"LEAD Therapeutics","permalink":"lead-therapeutics","image":{"available_sizes":[[[150,120],"assets/images/resized/0005/2996/52996v1-max-150x150.jpg"],[[162,130],"assets/images/resized/0005/2996/52996v1-max-250x250.jpg"],[[162,130],"assets/images/resized/0005/2996/52996v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.flowcardia.com/about_news_n10.htm","source_description":"FlowCardia, Inc. Raises $30 Million In Series C Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":8,"funded_day":30,"company":{"name":"FlowCardia","permalink":"flowcardia","image":{"available_sizes":[[[150,27],"assets/images/resized/0005/3136/53136v1-max-150x150.jpg"],[[250,45],"assets/images/resized/0005/3136/53136v1-max-250x250.jpg"],[[414,76],"assets/images/resized/0005/3136/53136v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://deals.venturebeat.com/2009/08/24/barosense-bags-27m-for-obesity-treatment/","source_description":"Barosense bags $27M for obesity treatment","raised_amount":27000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":24,"company":{"name":"Barosense","permalink":"barosense","image":{"available_sizes":[[[150,36],"assets/images/resized/0005/7510/57510v1-max-150x150.jpg"],[[250,61],"assets/images/resized/0005/7510/57510v1-max-250x250.jpg"],[[430,105],"assets/images/resized/0005/7510/57510v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.biosyntech.com/en/newsroom/press.aspx?ID=119","source_description":"BioSyntech Announces $4.5 Million Financing","raised_amount":1400000,"raised_currency_code":"USD","funded_year":2009,"funded_month":8,"funded_day":14,"company":{"name":"Biosyntech","permalink":"biosyntech","image":{"available_sizes":[[[150,93],"assets/images/resized/0006/1162/61162v1-max-150x150.png"],[[210,131],"assets/images/resized/0006/1162/61162v1-max-250x250.png"],[[210,131],"assets/images/resized/0006/1162/61162v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2010/01/liquidia-technologies-raises-20m-in.html","source_description":"Liquidia Technologies Raises $20M in Series C Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":19,"company":{"name":"Liquidia Technologies","permalink":"liquidia-technologies","image":{"available_sizes":[[[150,57],"assets/images/resized/0006/2237/62237v1-max-150x150.jpg"],[[176,68],"assets/images/resized/0006/2237/62237v1-max-250x250.jpg"],[[176,68],"assets/images/resized/0006/2237/62237v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.cequentpharma.com/NovartisRelease.pdf","source_description":"Cequent Pharmaceuticals","raised_amount":9000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":18,"company":{"name":"Cequent Pharmaceuticals","permalink":"cequent-pharmaceuticals","image":{"available_sizes":[[[150,41],"assets/images/resized/0006/6015/66015v1-max-150x150.png"],[[250,69],"assets/images/resized/0006/6015/66015v1-max-250x250.png"],[[299,83],"assets/images/resized/0006/6015/66015v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2009/12/afferent-pharmaceuticals-closes-23m.html","source_description":"Afferent Pharmaceuticals Closes $23M Series A Financing Round","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":12,"funded_day":16,"company":{"name":"Afferent Pharmaceuticals","permalink":"afferent-pharmaceuticals","image":{"available_sizes":[[[150,42],"assets/images/resized/0007/6112/76112v1-max-150x150.png"],[[250,71],"assets/images/resized/0007/6112/76112v1-max-250x250.png"],[[263,75],"assets/images/resized/0007/6112/76112v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://venturebeat.com/2007/06/21/gentis-raises-10m-for-spine-injected-implants/","source_description":"Gentis raises $10M for spine-injected implants","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":21,"company":{"name":"Gentis","permalink":"gentis","image":{"available_sizes":[[[150,75],"assets/images/resized/0008/0343/80343v1-max-150x150.jpg"],[[206,103],"assets/images/resized/0008/0343/80343v1-max-250x250.jpg"],[[206,103],"assets/images/resized/0008/0343/80343v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/syndax-pharmaceuticals-inc-series-a-9m/","source_description":"Syndax Pharmaceuticals, Inc.: Series A $9M","raised_amount":9000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":16,"company":{"name":"Syndax Pharmaceuticals","permalink":"sndax-pharmaceuticals","image":{"available_sizes":[[[150,60],"assets/images/resized/0008/0485/80485v1-max-150x150.png"],[[206,83],"assets/images/resized/0008/0485/80485v1-max-250x250.png"],[[206,83],"assets/images/resized/0008/0485/80485v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/cardiodx-inc-series-d-345m/","source_description":"CardioDx, Inc.: Series D $34.5M","raised_amount":34500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":17,"company":{"name":"CardioDx","permalink":"cardiodx","image":{"available_sizes":[[[132,98],"assets/images/resized/0006/0777/60777v1-max-150x150.png"],[[132,98],"assets/images/resized/0006/0777/60777v1-max-250x250.png"],[[132,98],"assets/images/resized/0006/0777/60777v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/liquidia-technologies-inc-series-c-5m/","source_description":"Liquidia Technologies, Inc.: Series C $5M","raised_amount":5000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":7,"funded_day":13,"company":{"name":"Liquidia Technologies","permalink":"liquidia-technologies","image":{"available_sizes":[[[150,57],"assets/images/resized/0006/2237/62237v1-max-150x150.jpg"],[[176,68],"assets/images/resized/0006/2237/62237v1-max-250x250.jpg"],[[176,68],"assets/images/resized/0006/2237/62237v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.cenerx.com/News/releases/13-AUG-10.pdf","source_description":"CENERX BIOPHARMA COMPLETES $13 MILLION SERIES C FINANCING","raised_amount":13000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":13,"company":{"name":"CeNeRx BioPharma","permalink":"cenerx-biopharma","image":{"available_sizes":[[[150,90],"assets/images/resized/0009/7652/97652v1-max-150x150.jpg"],[[200,120],"assets/images/resized/0009/7652/97652v1-max-250x250.jpg"],[[200,120],"assets/images/resized/0009/7652/97652v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://ir.achillion.com/releasedetail.cfm?ReleaseID=500371","source_description":"Achillion Announces Private Placement of $50 Million","raised_amount":50100000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":18,"company":{"name":"Achillion Pharmaceuticals","permalink":"achillion-pharmaceuticals","image":{"available_sizes":[[[150,34],"assets/images/resized/0006/0871/60871v2-max-150x150.png"],[[250,56],"assets/images/resized/0006/0871/60871v2-max-250x250.png"],[[303,69],"assets/images/resized/0006/0871/60871v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.tyrx.com/Collateral/Documents/TyRx%20English-US/MKT-23-092%20TYRX%20Funding112910-%20Final.pdf","source_description":"TYRX, Inc. Raises $20 Million in Private Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":12,"funded_day":8,"company":{"name":"TyRx Pharma","permalink":"tyrx-pharma","image":{"available_sizes":[[[150,42],"assets/images/resized/0011/3429/113429v1-max-150x150.png"],[[160,45],"assets/images/resized/0011/3429/113429v1-max-250x250.png"],[[160,45],"assets/images/resized/0011/3429/113429v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"f","source_url":"http://www.chimerix-inc.com/news-and-resources/news-and-resources-details/chimerix-completes-45-million-financing/","source_description":"Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157 ","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":14,"company":{"name":"Chimerix","permalink":"chimerix","image":{"available_sizes":[[[150,60],"assets/images/resized/0005/6041/56041v1-max-150x150.png"],[[245,98],"assets/images/resized/0005/6041/56041v1-max-250x250.png"],[[245,98],"assets/images/resized/0005/6041/56041v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/05/cardiodx-closes-60m-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"CardioDx Closes $60m Financing Round","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":5,"funded_day":11,"company":{"name":"CardioDx","permalink":"cardiodx","image":{"available_sizes":[[[132,98],"assets/images/resized/0006/0777/60777v1-max-150x150.png"],[[132,98],"assets/images/resized/0006/0777/60777v1-max-250x250.png"],[[132,98],"assets/images/resized/0006/0777/60777v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://money.msn.com/business-news/article.aspx?feed=PR&Date=20110613&ID=13761722&topic=TOPIC_FINANCING&isub=1","source_description":"Milestone Pharmaceuticals Announces $13 Million Equity Financing","raised_amount":13000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":13,"company":{"name":"Milestone Pharmaceuticals","permalink":"milestone-pharmaceuticals","image":{"available_sizes":[[[150,46],"assets/images/resized/0013/8995/138995v1-max-150x150.jpg"],[[250,77],"assets/images/resized/0013/8995/138995v1-max-250x250.jpg"],[[288,89],"assets/images/resized/0013/8995/138995v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/06/ultragenyx-pharmaceutical-closes-45m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Ultragenyx Pharmaceutical Closes $45M Series A Financing","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":20,"company":{"name":"Ultragenyx Pharmaceutical","permalink":"ultragenyx-pharmaceutical","image":{"available_sizes":[[[150,57],"assets/images/resized/0014/0132/140132v1-max-150x150.png"],[[210,80],"assets/images/resized/0014/0132/140132v1-max-250x250.png"],[[210,80],"assets/images/resized/0014/0132/140132v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/06/tesaro-secures-101m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"TESARO Secures $101M in Series B Financing","raised_amount":101000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":21,"company":{"name":"TESARO","permalink":"tesaro","image":{"available_sizes":[[[150,32],"assets/images/resized/0008/8913/88913v1-max-150x150.jpg"],[[250,54],"assets/images/resized/0008/8913/88913v1-max-250x250.jpg"],[[312,68],"assets/images/resized/0008/8913/88913v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.prnewswire.com/news-releases/colucid-pharmaceuticals-raises-75-million-of-planned-95-million-128664483.html","source_description":"CoLucid Pharmaceuticals Raises $7.5 Million of Planned $9.5 Million","raised_amount":7500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":8,"funded_day":30,"company":{"name":"CoLucid Pharmaceuticals","permalink":"colucid-pharmaceuticals","image":{"available_sizes":[[[150,57],"assets/images/resized/0015/1961/151961v1-max-150x150.png"],[[210,81],"assets/images/resized/0015/1961/151961v1-max-250x250.png"],[[210,81],"assets/images/resized/0015/1961/151961v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/cenerx-biopharma-inc-series-d-46m/","source_description":"CeNeRx BioPharma, Inc.: Series D $4.6M","raised_amount":4600000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":3,"company":{"name":"CeNeRx BioPharma","permalink":"cenerx-biopharma","image":{"available_sizes":[[[150,90],"assets/images/resized/0009/7652/97652v1-max-150x150.jpg"],[[200,120],"assets/images/resized/0009/7652/97652v1-max-250x250.jpg"],[[200,120],"assets/images/resized/0009/7652/97652v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.marketwire.com/press-release/illuminoss-medical-secures-28-million-series-c-financing-minimally-invasive-bone-fracture-nyse-hqh-1706365.htm","source_description":"IlluminOss Medical Secures $28 Million Series C Financing for Minimally Invasive Bone Fracture Repair","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":27,"company":{"name":"IlluminOss Medical","permalink":"illuminoss-medical","image":{"available_sizes":[[[150,45],"assets/images/resized/0016/4547/164547v1-max-150x150.jpg"],[[250,75],"assets/images/resized/0016/4547/164547v1-max-250x250.jpg"],[[328,99],"assets/images/resized/0016/4547/164547v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.businesswire.com/news/edmontonjournal/20121025005392/en/Thrasos-Secures-35-Million-Fund-THR-184-Phase","source_description":"Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":10,"funded_day":25,"company":{"name":"Thrasos","permalink":"thrasos","image":{"available_sizes":[[[150,56],"assets/images/resized/0021/7327/217327v1-max-150x150.jpg"],[[250,94],"assets/images/resized/0021/7327/217327v1-max-250x250.jpg"],[[252,95],"assets/images/resized/0021/7327/217327v1-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[],"video_embeds":[],"external_links":[]}